Assignee
NEOGAP THERAPEUTICS AB
SE·2 granted patents·5 pending applications·1 citations·filing 2016–2025
Top patents by PatentIndex Score
7 records- 0178US2025206793A1T-cell expansion method and usesNEOGAP THERAPEUTICS AB·Filed 2024·Application pending·0 cites
- 0275US2025388636A1T-cell expansion method and usesNEOGAP THERAPEUTICS AB·Filed 2025·Application pending·0 cites
- 0371US11360079B2T-cell reactivity platformNEOGAP THERAPEUTICS AB·Filed 2016·Granted Jun 14, 2022·1 cites·19 claims
- 0468US2024158455A1Multiple sclerosis associated autoantigens, and use thereof in therapy and diagnosisNEOGAP THERAPEUTICS AB·Filed 2023·Application pending·0 cites
- 0567US2022381771A1T-cell reactivity platformNEOGAP THERAPEUTICS AB·Filed 2022·Application pending·0 cites
- 0650US12377141B2Method for the expansion of HPV immunogen specific T-cellsNEOGAP THERAPEUTICS AB·Filed 2019·Granted Aug 5, 2025·0 cites·17 claims
- 0749US2022111041A1Phagocytisable particle for use in the treatment or prophylaxis of cancerNEOGAP THERAPEUTICS AB·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NEOGAP THERAPEUTICS AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →